Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and deletion of notices about government funding lapse and prior Revision: v3.4.1. These updates are administrative in nature and do not modify study data or core page content.
    Difference
    0.5%
    Check dated 2026-02-11T09:27:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding status banner noting possible delays and open status, and updated the site version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:20:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and new footer items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed or altered the previous items/labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:22:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision metadata updated: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:18:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a Locations section with a California site and updated the page revision to v3.3.3; the prior California Locations listing was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:00:54.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Updated: Study Protocol and Statistical Analysis Plan to revision v3.3.2, replacing v3.3.1. This is an administrative document revision and does not alter core trial details or reported results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.